Mutations of MYL3 have been associated with familial hypertrophic cardiomyopathy (FHC), and, although these mutations are rare when compared with mutations in MYH7, the outcomes of these mutations are quite malignant. This evidence concerns the gene MYL3 and hypercholesterolemia, familial, 1.